The Rotator Cuff Injury Treatment Market size was estimated USD 989.3 million in 2022 and is expected to reach USD 1439.5 million by 2030 at a CAGR of 4.8% during the forecast period of 2023-2030.
The latest research study includes market buying patterns, price analysis, patent analysis, conference and webinar materials, and industry trends. The rise in sports-related shoulder injuries, technological developments in arthroscopic surgical devices, an ageing population with an increase in osteoarthritis, and a strong focus on the release of highly advanced arthroscopic treatment devices by players are the main drivers of this market's growth. On the other hand, market participants offering solutions for treating rotator cuff injuries face significant difficulties due to a lack of competent specialists, a high incidence of surgical treatment failure, and their high cost.
The shoulder can experience a lot of stress from sports and shoulder-related physical activity, which can lead to rotator cuff tendonitis, shoulder discomfort, and weakness that further limits arm movement. Three-quarters of all sports injuries involve the upper extremities. According to "Clinical Orthopaedics and Related Research," published in the Association of Bone and Joint Surgeons publication, according to research "released in 2022, rotator cuff injuries are most frequently caused by old age and repetitive shoulder movements in basketball, tennis, swimming, and other sports.
DRIVERS
Sports-related shoulder injuries are becoming more common.
RESTRAIN
Arthroscopic surgical procedures have high expenses.
The high expense of arthroscopic surgery is a significant concern, particularly in developing nations like China and India, where a lower percentage of the population is covered by insurance. In India, the typical cost of an outpatient shoulder arthroscopy can be between 2000 and 6,000 dollars. The affordability of shoulder arthroscopy has decreased as a result of these expensive procedures, which is preventing this industry from expanding. Additionally, surgical settings in low-resource income countries are extremely hesitant to accept innovative products due to a lack of knowledge and affordability, which is anticipated to somewhat impede the expansion of this market.
OPPORTUNITY
New orthobiologics are being developed.
Regenerative biologics are a fast-expanding market that has the potential to profoundly alter sports orthopaedics.
CHALLENGES
High surgical failure rates for rotator cuff injuries.
The frequency of rotator cuff injuries is rising, and the tears must be repaired immediately by surgery. The surgical treatment of rotator cuffs still has a high failure rate, which is quite concerning. Despite advancements in rotator cuff surgical methods, the likelihood of re-tear is still around 10–20% and rises with the degree of the tear, impeding the expansion of the worldwide market as a whole.
The Ukraine-Russian War, especially the fighting in the east, has the potential to have an effect on a number of businesses, including healthcare. Due to the interruptions brought on by the fighting, such as destroyed infrastructure, limited access to medical facilities and supplies, and population relocation, the medical market in the area may have encountered difficulties. These elements could have had an impact on the accessibility and quality of medical care, particularly the management of rotator cuff problems. Geopolitical tensions and economic sanctions during the conflict may also have had wider ramifications for commerce and investment on a global scale, which might have indirectly affected the healthcare sector, particularly medicines and medical equipment.
The complex nature of the healthcare sector and the multiplicity of factors that might affect market dynamics must always be kept in mind. The duration and severity of the Russia-Ukraine War, geopolitical developments, economic conditions, and the reactions of the healthcare industry and regulatory bodies are just a few of the regional and international factors that could have an impact on the market for treating rotator cuff injuries.
IMPACT OF ONGOING RECESSION
Impact on Healthcare Providers Throughout a recession, healthcare providers could face financial difficulties as a result of decreased patient numbers and postponed or cancelled elective treatments. Their capacity to fund innovative technology, cutting-edge research, and specialised therapies may be impacted by these financial constraints. Economic downturns can result in decreased demand for medicines and medical devices, which could have an impact on the creation of novel therapies and technologies for rotator cuff problems. Regulation and Compensation Governments may alter their financing and reimbursement policies for healthcare during recessions. These modifications may affect the accessibility and cost of rotator cuff injury therapies.
By Treatment
Surgical treatment or curative treatment
Arthroscopy (tendon repair)
Traditional/Open surgeries
Shoulder Replacement Surgery
Open Tendon Repair or Transfer
Physiotherapy or Palliative treatment
Orthopedic braces
Cold compression therapy
Pharmaceutical drugs or preventive treatment
Anti-inflammatory drugs & pain killers
Injections
Orthobiologics
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
REGIONAL ANALYSES
In 2022, North America held the greatest revenue share in the market, at 40-45%. This is attributable to continued R&D, an increase in the number of product releases, and the commercialization of cutting-edge rotator cuff injury therapies. Additionally, with the rising investment and number of collaborations among big businesses, as well as the supportive regulatory framework for rotator cuff surgery, the market is boosted by operations and government regulations that stimulate the sale of related items. Additionally, the region will be able to continue its supremacy during the projection period because of the significant participation in sports.
Considering the development of the healthcare infrastructure and favourable regulations for reimbursement for the treatment of rotator cuff ailment, Europe will experience tremendous growth in this market. Additionally, this area has constructed new sports infrastructure, which might increase the prevalence of shoulder injuries and benefit this industry.
The major Key players are Arthrex, Inc, Zimmer Biomet, FH ORTHOPEDICS S.A.S, Integra LifeSciences, Reckitt Benckiser Group PLC, Evolutis India Pvt. Ltd., Johnson & Johnson, GlaxoSmithKline pic, CONMED Corporation and others.
Embody Inc: In 31st May 2022, The TAPESTRY RC device from soft tissue healing business Embody Inc. has received FDA clearance to treat rotator cuff problems. It combines the TAPESTRY biointegrative collagen implant's healing benefits with streamlined delivery and the insertion of bioabsorbable anchors.
Stryker: In 3rd May 2022, The Journal of Bone & Joint Surgery (JBJS) has published findings from a multicenter, single-blind, randomised controlled study comparing Stryker's InSpace implant with partial repair for the treatment of full-thickness Major Rotator Cuff Tears (MIRCTs). In the research, the effectiveness and safety of Stryker's InSpace implant were compared to those of arthroscopic partial repair in patients with irreparable injuries.
| Report Attributes | Details |
| Market Size in 2022 | US$ 989.3 Mn |
| Market Size by 2030 | US$ 1439.5 Mn |
| CAGR | CAGR of 4.8 % From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Treatment (Surgical treatment or curative treatment, Physiotherapy or Palliative treatment, pharmaceutical drugs or preventive treatment, Orthobiologics) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Arthrex, Inc, Zimmer Biomet, FH ORTHOPEDICS S.A.S, Integra LifeSciences, Reckitt Benckiser Group PLC, Evolutis India Pvt. Ltd., Johnson & Johnson, GlaxoSmithKline pic, CONMED Corporation |
| Key Drivers | • Sports-related shoulder injuries are becoming more common. |
| Market Restraints | • Arthroscopic surgical procedures have high expenses. |
Ans: The Rotator Cuff Injury Treatment Market is expected to grow at a 4.8% CAGR from 2023 to 2030.
Ans: According to our analysis, the Rotator Cuff Injury Treatment Market is anticipated to reach USD 1508.9 billion by 2030.
Ans: The prominent players in the Rotator Cuff Injury Treatment Market are Arthrex, Inc, Zimmer Biomet, FH ORTHOPEDICS S.A.S, Integra Life Sciences, Reckitt Benckiser Group PLC.
Ans: Shoulder replacement surgery may be necessary for severe rotator cuff problems. Reverse shoulder arthroplasty is a novel surgery that installs the ball portion of the artificial joint on the shoulder blade and the socket portion on the arm bone to increase the stability of the artificial joint.
Ans: Yes, you may request customization based on your company's needs.
TABLE OF CONTENT
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4 Impact of Russia-Ukraine war
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Rotator Cuff Injury Treatment Market, By Treatment
8.1 Surgical treatment or curative treatment
8.2 Physiotherapy or Palliative treatment
8.3 Pharmaceutical drugs or preventive treatment
8.4 Orthobiologics
9. Regional Analysis
9.1 Introduction
9.2 North America
9.2.1 North America Rotator Cuff Injury Treatment Market by Country
9.2.2 North America Rotator Cuff Injury Treatment Market by Treatment
9.2.3 USA
9.2.3.1 USA Rotator Cuff Injury Treatment Market by Treatment
9.2.4 Canada
9.2.4.1 Canada Rotator Cuff Injury Treatment Market by Treatment
9.2.5 Mexico
9.2.5.1 Mexico Rotator Cuff Injury Treatment Market by Treatment
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Eastern Europe Rotator Cuff Injury Treatment Market by Country
9.3.1.2 Eastern Europe Rotator Cuff Injury Treatment Market by Treatment
9.3.1.3 Poland
9.3.1.4.1 Poland Rotator Cuff Injury Treatment Market by Treatment
9.3.1.4 Romania
9.3.1.4.1 Romania Rotator Cuff Injury Treatment Market by Treatment
9.3.1.5 Hungary
9.3.1.5.1 Hungary Rotator Cuff Injury Treatment Market by Treatment
9.3.1.6 Turkey
9.3.1.6.1 Turkey Rotator Cuff Injury Treatment Market by Treatment
9.3.1.7 Rest of Eastern Europe
9.3.1.7.1 Rest of Eastern Europe Rotator Cuff Injury Treatment Market by Treatment
9.3.2 Western Europe
9.3.2.1 Western Europe Rotator Cuff Injury Treatment Market by Country
9.3.2.2 Western Europe Rotator Cuff Injury Treatment Market by Treatment
9.3.2.3 Germany
9.3.2.3.1 Germany Rotator Cuff Injury Treatment Market by Treatment
9.3.2.4 France
9.3.2.4.1 France Rotator Cuff Injury Treatment Market by Treatment
9.3.2.5 UK
9.3.2.5.1 UK Rotator Cuff Injury Treatment Market by Treatment
9.3.2.6 Italy
9.3.2.6.1 Italy Rotator Cuff Injury Treatment Market by Treatment
9.3.2.7 Spain
9.3.2.7.1 Spain Rotator Cuff Injury Treatment Market by Treatment
9.3.2.8 Netherlands
9.3.2.8.1 Netherlands Rotator Cuff Injury Treatment Market by Treatment
9.3.2.9 Switzerland
9.3.2.9.1 Switzerland Rotator Cuff Injury Treatment Market by Treatment
9.3.2.10 Austria
9.3.2.10.1 Austria Rotator Cuff Injury Treatment Market by Treatment
9.3.2.11 Rest of Western Europe
9.3.2.11.1 Rest of Western Europe Rotator Cuff Injury Treatment Market by Treatment
9.4 Asia-Pacific
9.4.1 Asia Pacific Rotator Cuff Injury Treatment Market by Country
9.4.2 Asia Pacific Rotator Cuff Injury Treatment Market by Treatment
9.4.3 China
9.4.3.1 China Rotator Cuff Injury Treatment Market by Treatment
9.4.4 India
9.4.4.1 India Rotator Cuff Injury Treatment Market by Treatment
9.4.5 Japan
9.4.5.1 Japan Rotator Cuff Injury Treatment Market by Treatment
9.4.6 South Korea
9.4.6.1 South Korea Rotator Cuff Injury Treatment Market by Treatment
9.4.7 Vietnam
9.4.7.1 Vietnam Rotator Cuff Injury Treatment Market by Treatment
9.4.8 Singapore
9.4.8.1 Singapore Rotator Cuff Injury Treatment Market by Treatment
9.4.9 Australia
9.4.9.1 Australia Rotator Cuff Injury Treatment Market by Treatment
9.4.10 Rest of Asia-Pacific
9.4.10.1 Rest of Asia-Pacific Rotator Cuff Injury Treatment Market by Treatment
9.5 Middle East & Africa
9.5.1 Middle East
9.5.1.1 Middle East Rotator Cuff Injury Treatment Market by Country
9.5.1.2 Middle East Rotator Cuff Injury Treatment Market by Treatment
9.5.1.3 UAE
9.5.1.3.1 UAE Rotator Cuff Injury Treatment Market by Treatment
9.5.1.4 Egypt
9.5.1.4.1 Egypt Rotator Cuff Injury Treatment Market by Treatment
9.5.1.5 Saudi Arabia
9.5.1.5.1 Saudi Arabia Rotator Cuff Injury Treatment Market by Treatment
9.5.1.6 Qatar
9.5.1.6.1 Qatar Rotator Cuff Injury Treatment Market by Treatment
9.5.1.7 Rest of Middle East
9.5.1.7.1 Rest of Middle East Rotator Cuff Injury Treatment Market by Treatment
9.5.2 Africa
9.5.2.1 Africa Rotator Cuff Injury Treatment Market by Country
9.5.2.2 Africa Rotator Cuff Injury Treatment Market by Treatment
9.5.2.3 Nigeria
9.5.2.3.1 Nigeria Rotator Cuff Injury Treatment Market by Treatment
9.5.2.4 South Africa
9.5.2.4.1 South Africa Rotator Cuff Injury Treatment Market by Treatment
9.5.2.5 Rest of Africa
9.5.2.5.1 Rest of Africa Rotator Cuff Injury Treatment Market by Treatment
9.6 Latin America
9.6.1 Latin America Rotator Cuff Injury Treatment Market by Country
9.6.2 Latin America Rotator Cuff Injury Treatment Market by Treatment
9.6.3 Brazil
9.6.3.1 Brazil Rotator Cuff Injury Treatment Market by Treatment
9.6.4 Argentina
9.6.4.1 Argentina Rotator Cuff Injury Treatment Market by Treatment
9.6.5 Colombia
9.6.5.1 Colombia Rotator Cuff Injury Treatment Market by Treatment
9.6.6 Rest of Latin America
9.6.6.1 Rest of Latin America Rotator Cuff Injury Treatment Market by Treatment
10 Company Profile
10.1 Arthrex, Inc.
10.1.1 Company Overview
10.1.2 Financials
10.1.3 Product/Services/Offerings
10.1.4 SWOT Analysis
10.1.5 The SNS View
10.2 Zimmer Biomet.
10.2.1 Company Overview
10.2.2 Financials
10.2.3 Product/Services/Offerings
10.2.4 SWOT Analysis
10.2.5 The SNS View
10.3 FH ORTHOPEDICS S.A.S.
10.3.1 Company Overview
10.3.2 Financials
10.3.3 Product/Services/Offerings
10.3.4 SWOT Analysis
10.3.5 The SNS View
10.4 Integra LifeSciences.
10.4 Company Overview
10.4.2 Financials
10.4.3 Product/Services/Offerings
10.4.4 SWOT Analysis
10.4.5 The SNS View
10.5 Reckitt Benckiser Group PLC.
10.5.1 Company Overview
10.5.2 Financials
10.5.3 Product/Services/Offerings
10.5.4 SWOT Analysis
10.5.5 The SNS View
10.6 Evolutis India Pvt. Ltd.
10.6.1 Company Overview
10.6.2 Financials
10.6.3 Product/Services/Offerings
10.6.4 SWOT Analysis
10.6.5 The SNS View
10.7 Johnson & Johnson.
10.7.1 Company Overview
10.7.2 Financials
10.7.3 Product/Services/Offerings
10.7.4 SWOT Analysis
10.7.5 The SNS View
10.8 GlaxoSmithKline pic.
10.8.1 Company Overview
10.8.2 Financials
10.8.3 Product/Services/Offerings
10.8.4 SWOT Analysis
10.8.5 The SNS View
10.9 CONMED Corporation
10.9.1 Company Overview
10.9.2 Financials
10.9.3 Product/Services /Offerings
10.9.4 SWOT Analysis
10.9.5 The SNS View
10.10 Ontex.
10.10.1 Company Overview
10.10.2 Financials
10.10.3 Product/Services/Offerings
10.10.4 SWOT Analysis
10.10.5 The SNS View
11. Competitive Landscape
11.1 Competitive Bench marking
11.2 Market Share Analysis
11.3 Recent Developments
11.3.1 Industry News
11.3.2 Company News
11.3.3 Mergers & Acquisitions
12. USE Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Digital PCR-dPCR Market size was valued at US$ 419.25 Million in 2022 and is projected to reach US$ 2196.40 Million by 2030, with a growing CAGR of 23% during the forecast period 2023-2030.
The Transplantation Market was estimated at USD 15.2 billion in 2022 and is poised to reach at 31.18 billion in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of 9.4% for the forecast period of 2023-2030.
The Cell & Gene Therapy Manufacturing Services Market Size was valued at USD 6.1 billion in 2023 and is expected to reach USD 38.9 billion by 2031 and grow at a CAGR of 22.3% over the forecast period 2024-2031.
The Urinalysis Market Size was valued at USD 4.06 billion in 2022 and is expected to reach USD 6.98 billion by 2030, and grow at a CAGR of 7% over the forecast period 2023-2030.
The mHealth Market size is expected to reach USD 127 Bn by 2030, the base value of the market was valued at USD 56.8 Bn in 2022. The CAGR growth rate was recorded 10.6% over the forecast period of 2023-2030.
The Softgel Capsule Market Size was valued at USD 8.18 billion in 2023 and is expected to reach USD 14.06 billion by 2031 and grow at a CAGR of 7% over the forecast period 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
